Financial Management Professionals’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed -$984 948
2025
Q2
$984 Hold
10
﹤0.01% 831
2025
Q1
$926 Hold
10
﹤0.01% 822
2024
Q4
$908 Hold
10
﹤0.01% 822
2024
Q3
$1K Hold
10
﹤0.01% 784
2024
Q2
$1K Hold
10
﹤0.01% 742
2024
Q1
$1K Hold
10
﹤0.01% 803
2023
Q4
$1K Hold
10
﹤0.01% 800
2023
Q3
$1K Hold
10
﹤0.01% 751
2023
Q2
$1K Hold
10
﹤0.01% 786
2023
Q1
$1K Hold
10
﹤0.01% 844
2022
Q4
$1K Hold
10
﹤0.01% 789
2022
Q3
$1K Hold
10
﹤0.01% 793
2022
Q2
$1K Sell
10
-6
-38% -$767 ﹤0.01% 798
2022
Q1
$3K Hold
16
﹤0.01% 695
2021
Q4
$3K Hold
16
﹤0.01% 640
2021
Q3
$2K Hold
16
﹤0.01% 690
2021
Q2
$4K Buy
+16
New +$4.2K ﹤0.01% 539
2018
Q4
Sell
-79
Closed -$10K 276
2018
Q3
$10K Buy
+79
New +$8.72K ﹤0.01% 162

Other funds holding AMED

Financial Management Professionals's AMED Position: Q3 2025 in Review

Financial Management Professionals sold out of Amedisys (AMED) in Q3 2025, closing a stake of 10 shares — an estimated $984 sold.

Financial Management Professionals first reported a position in AMED in Q3 2018 and held it in 18 quarters. The position peaked at $10K in Q3 2018. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Financial Management Professionals reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Financial Management Professionals sold 10 Amedisys shares in Q3 2025, an estimated $984.
  • Financial Management Professionals first reported a position in Amedisys in Q3 2018 and held it in 18 quarters.
  • Financial Management Professionals's Amedisys position peaked at $10K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Financial Management Professionals's 13F filing for Q3 2025, filed 15 Oct 2025.